NO20035319D0 - En G-proteinkoblet reseptor og anvendelse derav - Google Patents

En G-proteinkoblet reseptor og anvendelse derav

Info

Publication number
NO20035319D0
NO20035319D0 NO20035319A NO20035319A NO20035319D0 NO 20035319 D0 NO20035319 D0 NO 20035319D0 NO 20035319 A NO20035319 A NO 20035319A NO 20035319 A NO20035319 A NO 20035319A NO 20035319 D0 NO20035319 D0 NO 20035319D0
Authority
NO
Norway
Prior art keywords
protein
coupled receptor
receptor
coupled
Prior art date
Application number
NO20035319A
Other languages
English (en)
Norwegian (no)
Inventor
Maria Blatcher
Brian Gaither Bates
Janet Elizabeth Paulsen
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20035319D0 publication Critical patent/NO20035319D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO20035319A 2001-06-07 2003-11-28 En G-proteinkoblet reseptor og anvendelse derav NO20035319D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29713101P 2001-06-07 2001-06-07
PCT/US2002/016834 WO2002101005A2 (en) 2001-06-07 2002-05-30 A g-protein coupled receptor and uses therefor

Publications (1)

Publication Number Publication Date
NO20035319D0 true NO20035319D0 (no) 2003-11-28

Family

ID=23144983

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20035319A NO20035319D0 (no) 2001-06-07 2003-11-28 En G-proteinkoblet reseptor og anvendelse derav

Country Status (10)

Country Link
US (3) US20030022211A1 (ja)
EP (1) EP1392845A4 (ja)
JP (1) JP2004537297A (ja)
BR (1) BR0210283A (ja)
CA (1) CA2449649A1 (ja)
MX (1) MXPA03011260A (ja)
NO (1) NO20035319D0 (ja)
PL (1) PL370139A1 (ja)
WO (1) WO2002101005A2 (ja)
ZA (1) ZA200400074B (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5112557B2 (ja) 2009-02-19 2013-01-09 株式会社日立ハイテクノロジーズ 質量分析システム

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554101A (en) * 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US4873191A (en) * 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
US4522811A (en) * 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US4870009A (en) * 1982-11-22 1989-09-26 The Salk Institute For Biological Studies Method of obtaining gene product through the generation of transgenic animals
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4736866B1 (en) * 1984-06-22 1988-04-12 Transgenic non-human mammals
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4987071A (en) * 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
US5116742A (en) * 1986-12-03 1992-05-26 University Patents, Inc. RNA ribozyme restriction endoribonucleases and methods
US4873316A (en) * 1987-06-23 1989-10-10 Biogen, Inc. Isolation of exogenous recombinant proteins from the milk of transgenic mammals
US5080891A (en) * 1987-08-03 1992-01-14 Ddi Pharmaceuticals, Inc. Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5272057A (en) * 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5328470A (en) * 1989-03-31 1994-07-12 The Regents Of The University Of Michigan Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
US5733761A (en) * 1991-11-05 1998-03-31 Transkaryotic Therapies, Inc. Protein production and protein delivery
US6100042A (en) * 1993-03-31 2000-08-08 Cadus Pharmaceutical Corporation Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
US5498531A (en) * 1993-09-10 1996-03-12 President And Fellows Of Harvard College Intron-mediated recombinant techniques and reagents
US5691188A (en) * 1994-02-14 1997-11-25 American Cyanamid Company Transformed yeast cells expressing heterologous G-protein coupled receptor
US6004808A (en) * 1996-06-21 1999-12-21 Aurora Biosciences Corporation Promiscuous G-protein compositions and their use
FR2755536B1 (fr) * 1996-11-07 1998-12-04 Schneider Electric Sa Declencheur electromagnetique reglable et disjoncteur comportant un tel declencheur
US5891646A (en) * 1997-06-05 1999-04-06 Duke University Methods of assaying receptor activity and constructs useful in such methods
JP2003510027A (ja) * 1999-08-17 2003-03-18 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング Ｐｇｐｃｒ−３ポリペプチドおよびそのｄｎａ配列
EP1237909A2 (en) * 1999-11-16 2002-09-11 PHARMACIA & UPJOHN COMPANY Human g protein-coupled receptors
WO2001036471A2 (en) * 1999-11-17 2001-05-25 Arena Pharmaceuticals, Inc. Endogenous and non-endogenous versions of human g protein-coupled receptors
US6979564B2 (en) * 2000-10-20 2005-12-27 Millennium Pharmaceuticals, Inc. 80090, human fucosyltransferase nucleic acid molecules and uses thereof
US6902902B2 (en) * 2001-11-27 2005-06-07 Arena Pharmaceuticals, Inc. Human G protein-coupled receptors and modulators thereof for the treatment of metabolic-related disorders

Also Published As

Publication number Publication date
BR0210283A (pt) 2004-09-14
WO2002101005A3 (en) 2003-07-31
JP2004537297A (ja) 2004-12-16
US20030022211A1 (en) 2003-01-30
ZA200400074B (en) 2006-06-28
EP1392845A4 (en) 2005-10-05
PL370139A1 (en) 2005-05-16
CA2449649A1 (en) 2002-12-19
WO2002101005A2 (en) 2002-12-19
US20070031860A1 (en) 2007-02-08
EP1392845A2 (en) 2004-03-03
MXPA03011260A (es) 2004-02-27
US20090255004A1 (en) 2009-10-08

Similar Documents

Publication Publication Date Title
IS7040A (is) 5-HT viðtakabindlar og notkun þeirra
DK1417175T3 (da) Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
IS8032A (is) Kannabinóíð viðtakabindlar og notkun þeirra
DE60228803D1 (de) Schlaghammergerät
DK1446379T3 (da) Arylanilin-beta2-adrenergiske receptoragonister
DE60210134D1 (de) Befestigungsvorrichtung
DE60226620D1 (de) Anschlagpuffervorrichtung
DE60200809D1 (de) Verbindungsvorrichtung
DE50205649D1 (de) Befestigungsvorrichtung
DE60206248D1 (de) Cogenerations-vorrichtung
DE50208596D1 (de) Befestigungsvorrichtung
DE60222717D1 (de) Zündpille-Anschlusseinrichtung
DE60300310D1 (de) Keilvorrichtung
DE50113918D1 (de) Quengel-Orthese
NO20042500L (no) Chemokin-reseptorantagonister og metoder for anvendelse derav
NO20035319D0 (no) En G-proteinkoblet reseptor og anvendelse derav
DE50210546D1 (de) Verbindungsvorrichtung
DE60205008D1 (de) Kettelverfahren und -vorrichtung
DE50213177D1 (de) Befestigungsvorrichtung
DE60209885D1 (de) Crf receptor antagonisten
DK2048159T3 (da) T-cellereceptorfremvisning
AU2002358508A8 (en) G-protein coupled receptor lustr2 and uses thereof
ES1049338Y (es) Transportador bidireccional vibrante
NO20041776L (no) En ny G-proteinkoblet reseptor, GAVE10
DE50100597D1 (de) Stelleinrichtung

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application